agilon health Inc (AGL)

Nov 5, 2026

Shares of healthcare services company Agilon Health (AGL) surged 17.5% after reporting strong third-quarter 2026 earnings, swinging from a net loss to a net profit of $35 million and achieving significant revenue growth. The company also saw a recovery in adjusted EBITDA and a decline in its medical services expense ratio, indicating improved operating efficiency. Despite high volatility and a substantial year-to-date gain, the stock remains below its 52-week high.

Nov 5, 2026

Agilon Health (AGL) reported strong Q3 2026 earnings, with an adjusted profit of $1.97 per share, significantly beating analyst estimates of a loss. The company also exceeded revenue expectations, posting $1.52 billion against a consensus of $1.44 billion. Despite a mixed outlook for earnings estimate revisions, Agilon's stock has seen substantial year-to-date growth, outperforming the S&P 500.

Nov 4, 2026

Agilon Health exceeded its third-quarter guidance and raised its full-year 2026 outlook, driven by strong financial performance, favorable medical expense development, and effective clinical pathways. The company is focused on expanding its value-based care model, particularly within the Medicare Shared Savings Program, anticipating 40-50% ACO membership growth in 2027. Key initiatives include enhancing data capabilities for earlier patient intervention, advancing evidence-based clinical pathways for conditions like heart failure and dementia, and maintaining disciplined growth and payer contracting to ensure sustainable performance.